Gemphire Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Northville MI United States (2014)
Status: Acquired by NeuroBo Pharmaceuticals (2019)

Organization Overview

First Clinical Trial
2014
NCT02587364
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Gemphire Therapeutics, Inc.